NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
21.86
-0.93 (-4.08%)
Sep 10, 2026, 4:00 PM EDT - Market closed
NAMS Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, NAMS stock has a consensus rating of "Strong Buy" and an average price target of $51.56. The average 1-year stock price forecast is 135.86% higher than the current stock price, while the lowest is $38.3 (+75.21%) and the highest is $60.04 (+174.66%).
Price Target: $51.56 (+135.86%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NAMS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 12 | 12 | 12 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $52 | Buy | Reiterates | $52 | +137.88% | Sep 8, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $50 | Buy | Maintains | $50 | +128.73% | Sep 8, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 8, 2026 |
| Needham | Needham | Buy Maintains $48 | Buy | Maintains | $48 | +119.58% | Aug 7, 2026 |
| BMO Capital | BMO Capital | Buy Reiterates $58 | Buy | Reiterates | $58 | +165.32% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
29.10M
from 22.50M
Increased by 29.31%
Revenue Next Year
143.87M
from 29.10M
Increased by 394.41%
EPS This Year
-1.96
from -1.72
EPS Next Year
-1.60
from -1.96
EPS and Forward PE are based on non-GAAP adjusted numbers.